3,677
Views
17
CrossRef citations to date
0
Altmetric
Review Article

Cervical cancer screening decentralized policy adaptation: an African rural-context-specific systematic literature review

ORCID Icon, ORCID Icon, ORCID Icon, , , , , ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon & ORCID Icon show all
Article: 1587894 | Received 03 Nov 2018, Accepted 20 Feb 2019, Published online: 02 Apr 2019

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018. [Internet]. DOI:10.3322/caac.21492
  • Organization WH, Others. Projections of mortality and causes of death, 2015 and 2030. Geneva, Switzerland: The World Health Organization; 2015.
  • Randall TC, Ghebre R. Challenges in prevention and care delivery for women with cervical cancer in Sub-Saharan Africa. Front Oncol. 2016;6:160.
  • Chuang LT, Temin S, Camacho R, et al. Management and care of women with invasive cervical cancer: American society of clinical oncology resource-stratified clinical practice guideline. J Glob Oncol. 2016;2:311–14.
  • Sankaranarayanan R, Nessa A, Esmy PO, et al. Visual inspection methods for cervical cancer prevention. Best Pract Res Clin Obstet Gynaecol. 2012;26:221–232.
  • Fokom-Domgue J, Combescure C, Fokom-Defo V, et al. Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies. BMJ. 2015;351:h3084.
  • Blumenthal PD, Gaffikin L, Deganus S, et al. Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. Am J Obstet Gynecol. 2007;407:407.e1–e8,discussion 407.e8–e9.
  • Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005;353:2158–2168.
  • Goldie SJ, Kuhn L, Denny L, et al. Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. JAMA. 2001;285:3107–3115.
  • Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med. 2008;5:e132.
  • Mitchell SA, Chambers DA. Leveraging implementation science to improve cancer care delivery and patient outcomes. J Oncol Pract. 2017;13:523–529.
  • Tabak RG, Khoong EC, Chambers DA, et al. Bridging research and practice: models for dissemination and implementation research. Am J Prev Med. 2012;43:337–350.
  • Peters DH, Tran NT, Adam T, et al. Implementation research in health: a practical guide. Geneva, Switzerland: World Health Organization; 2013.
  • Peters DH, Bhuiya A, Ghaffar A. Engaging stakeholders in implementation research: lessons from the future health systems research programme experience. Health Res Policy Syst. 2017;15:104.
  • Brownson RC, Colditz GA, Proctor EK. Dissemination and implementation research in health: translating science to practice.  New York, NY: Oxford University Press; 2017.
  • Denny L, Quinn M, Sankaranarayanan R. Chapter 8: screening for cervical cancer in developing countries. Vaccine. 2006;24:S3/71–77.
  • Commission on health research for development. Health research: essential link to equity in development.  New York, NY: Oxford University Press; 1990.
  • Kilama WL. The 10/90 gap in sub-Saharan Africa: resolving inequities in health research. Acta Trop. 2009;112:S8–S15.
  • Doyal L. Gender and the 10/90 gap in health research. Bull World Health Organ. 2004;82:162–162.
  • De Savigny D, Adam T, Alliance for Health Policy and Systems Research, et al. Systems thinking for health systems strengthening. Geneva: Alliance for Health Policy and Systems Research: World Health Organization; 2009.
  • Freeman HP, Chu KC. Determinants of cancer disparities: barriers to cancer screening, diagnosis, and treatment. Surg Oncol Clin N Am. 2005;14:10–1016.
  • Suba EJ, Murphy SK, Donnelly AD, et al. Systems analysis of real-world obstacles to successful cervical cancer prevention in developing countries. Am J Public Health. 2006;96:480–487.
  • Bill, Foundation MG, McKinsey. Global health partnerships: assessing country consequences. Florham Park, NJ: McKinsey & Company Florham Park; 2005.
  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
  • Huezo C, Diaz S. Quality of care in family planning: clients’ rights and providers’ needs. Adv Contracept. 1993;2:129–139.
  • EngenderHealth. COPE handbook: a process for improving quality in health services ® revised edition. New York, NY: EngenderHealth; 2003.
  • EngenderHealth. COPE for cervical cancer prevention services: a toolbook to accompany the COPE handbook ® engenderhealth’s quality improvement series. EngenderHealth. [Internet]. 2004. Available from: http://screening.iarc.fr/doc/cope_cxca_toolbook.pdf
  • Dykens JA, Linn AM, Irwin T, et al. Implementing visual cervical cancer screening in Senegal: a cross-sectional study of risk factors and prevalence highlighting service utilization barriers. Int J Womens Health. 2017;9:59–67.
  • Levesque J-F, Harris MF, Russell G. Patient-centred access to health care: conceptualising access at the interface of health systems and populations. Int J Equity Health. 2013;12:18.
  • Chambers DA, Norton WE. The adaptome: advancing the science of intervention adaptation. Am J Prev Med. 2016;51:S124–S131.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Int Med. 2009;151:264–269, W64.
  • World bank country and lending groups [Internet]. World Bank Data Help Desk. [cited 2017 Jul 18]. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
  • Perng P, Perng W, Ngoma T, et al. Promoters of and barriers to cervical cancer screening in a rural setting in Tanzania. Int J Gynaecol Obstet. 2013;123:221–225.
  • Audet CM, Silva Matos C, Blevins M, et al. Acceptability of cervical cancer screening in rural Mozambique. Health Educ Res. 2012;27:544–551.
  • Mangoma JF, Chirenje MZ, Chimbari MJ, et al. An assessment of rural women’s knowledge, constraints and perceptions on cervical cancer screening: the case of two districts in Zimbabwe. Afr J Reprod Health. 2006;10:91–103.
  • Abiodun OA, Olu-Abiodun OO, Sotunsa JO, et al. Impact of health education intervention on knowledge and perception of cervical cancer and cervical screening uptake among adult women in rural communities in Nigeria. BMC Public Health. 2014;14:814.
  • Adetokunbo AO. The understanding and perception of service providers about the community-based cervical screening in Nigeria. Ann Trop Med Public Health. 2013;6:637.
  • Peters LM, Soliman AS, Bukori P, et al. Evidence for the need of educational programs for cervical screening in rural Tanzania. J Cancer Educ. 2010;25:153–159.
  • Sanghvi H, Limpaphayom KK, Plotkin M, et al. Cervical cancer screening using visual inspection with acetic acid: operational experiences from Ghana and Thailand. Reprod Health Matters. 2008;16:67–77.
  • Maseko FC, Chirwa ML, Muula AS. Client satisfaction with cervical cancer screening in Malawi. BMC Health Serv Res. 2014;14:420.
  • White HL, Mulambia C, Sinkala M, et al. Motivations and experiences of women who accessed “see and treat” cervical cancer prevention services in Zambia. J Psychosomatic Obstet Gynecol. 2012;33:91–98.
  • Chigbu CO, Onyebuchi AK, Ajah LO, et al. Motivations and preferences of rural Nigerian women undergoing cervical cancer screening via visual inspection with acetic acid. Int J Gynaecol Obstet. 2013;120:262–265.
  • Fort VK, Makin MS, Siegler AJ, Ault K, Rochat R. Barriers to cervical cancer screening in Mulanje, Malawi: a qualitative study. Patient Prefer Adherence [Internet]. 2011 Mar 14;5:125–31. Available from: http://dx.doi.org/10.2147/PPA.S1731.7
  • Paul P, Winkler JL, Bartolini RM, et al. Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam. Oncologist. 2013;18 Suppl:1278–1284.
  • Quentin W, Adu-Sarkodie Y, Terris-Prestholt F, et al. Costs of cervical cancer screening and treatment using visual inspection with acetic acid (VIA) and cryotherapy in Ghana: the importance of scale. Trop Med Int Health. 2011;16:379–389.
  • Chigbu CO, Onyebuchi AK. See-and-treat management of high-grade squamous intraepithelial lesions in a resource-constrained African setting. Int J Gynaecol Obstet. 2014;124:204–206.
  • Chigbu CO, Onyebuchi AK. Use of a portable diathermy machine for LEEP without colposcopy during see-and-treat management of VIA-positive cervical lesions in resource-poor settings. Int J Gynecol Obstetrics. 2014;125:99–102.
  • Moon TD, Silva-Matos C, Cordoso A, et al. Implementation of cervical cancer screening using visual inspection with acetic acid in rural Mozambique: successes and challenges using HIV care and treatment programme investments in Zambézia Province. J Int AIDS Soc. 2012;15:17406.
  • Levine LD, Chudnoff SG, Taylor K, et al. A 5-day educational program for teaching cervical cancer screening using visual inspection with acetic acid in low-resource settings. Int J Gynaecol Obstet. 2011;115:171–174.
  • Osingada CP, Ninsiima G, Chalo RN, et al. Determinants of uptake of cervical cancer screening services at a no-cost reproductive health clinic managed by nurse-midwives. Cancer Nurs. 2014;38:177–184.
  • World Bank Country and Lending Groups [Internet]. World bank data help desk. [cited 2017 Jul 18]. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
  • Chambers DA, Glasgow RE, Stange KC. The dynamic sustainability framework: addressing the paradox of sustainment amid ongoing change. Implement Sci. 2013;8:117.
  • de Sanjosé S. BLB-RLAGSBMMGDMJBF. human papillomavirus and related diseases report: senegal [Internet]. ©ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). 2017. Available from: http://www.hpvcentre.net/statistics/reports/SEN.pdf
  • Xi LF, Touré P, Critchlow CW, et al. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age. Int J Cancer. 2003;103:803–809.
  • Perry H, Morrow M, Davis T, et al. Care groups – an effective community- based delivery strategy for improving reproductive, maternal, neonatal and child health in high-mortality. Resource-Constrained Settings A Guide for Policy Makers and Donors; [Internet]. 2014. Available from: https://www.fsnnetwork.org/sites/default/files/resource_uploads/care_group_policy_guide_final_8_2014_0.pdf
  • Perry HB, Zulliger R, Rogers MM. Community health workers in low-, middle-, and high-income countries: an overview of their history, recent evolution, and current effectiveness. Annu Rev Public Health. 2014;35:399–421.
  • 2018 World Population Data Sheet [Internet]. [cited 2018 Oct 18]. Available from: http://www.worldpopdata.org/